Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05776264
Other study ID # AAAU4513
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 29, 2023
Est. completion date May 10, 2023

Study information

Verified date December 2023
Source Columbia University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to evaluate exercise strategies that motivate and relive stress in adults with cardiopulomnary conditions. The goals of this study are as follows: - To explore the feasibility (how easily it can be done) of using self-selected music during exercise training for adults with cardiopulmonary conditions. - To assess patient satisfaction of self-selected music with exercise for adults with cardiopulmonary conditions. - To explore the immediate effects of self-selected music on mood and symptoms (shortness of breath and fatigue) compared with listening to a podcast during their exercise training session Participants will: - Select 5-7 songs and 1 podcast to listen to during their treatment session - Walk on the treadmill while either listening to a podcast or music - Fill out surveys about their mood, symptoms (shortness of breath and fatigue), music/podcast, and exercise


Description:

Music2Move aims to assess if tailored music (music choices that are set to a certain beats per minute and are self-selected by the participant) improves mood while exercising in adults with chronic lung diseases, to ultimately motivate them to engage in physical activity more frequently. This trial will be conducted during their pulmonary rehabilitation session for two consecutive sessions. Researchers will flip a coin for a random order of music condition or no music condition for each participant. Researchers will meet with participants before the trial to collect music selections to be played during the pulmonary rehabilitation session. Mood will be assessed every 2 minutes during the trial using the Feeling Scale to examine the effect of tailored music selections on the participants tolerance for exercise and maximal limit exercise exertion during the session. Heart rate, oxygen level, fatigue, and affect (immediate emotional response), measure of breathlessness (feelings of shortness of breath) will also be assessed before and after the trial to examine the affect that tailored music has on physical measures of exercise. The results of this study could aid in finding motivational tools to improve exercise participation and adherence in adults with chronic respiratory disease.


Recruitment information / eligibility

Status Completed
Enrollment 14
Est. completion date May 10, 2023
Est. primary completion date May 10, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 85 Years
Eligibility Inclusion Criteria: - Diagnosed with a cardiopulmonary disease - Speaks and understands English Exclusion Criteria: - Require a hearing aid or have a hearing impairment that interferes with their ability to hear music or use headphones during the study. - Unable to engage in physical activity due to health conditions including neurological or musculoskeletal diseases. - Require =6 liters of supplemental oxygen during pulmonary rehabilitation sessions. - Younger than 21 years old. - Older than 85 years old. - Have uncontrolled anginal symptoms. - Unable to exercise on a treadmill.

Study Design


Intervention

Behavioral:
Music Condition
During one of the sessions, participants will listen to music while walking on the treadmill for 10 minutes.
Podcast Condition
During one of the sessions, participant will listen to a podcast for 10 minutes while walking on the treadmill.

Locations

Country Name City State
United States NewYork-Presbyterian Hospital-Columbia Pulmonary Rehabilitation New York New York

Sponsors (1)

Lead Sponsor Collaborator
Columbia University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary FACIT TS-G Score The Functional Assessment of Chronic Illness Therapy Treatment Satisfaction General (FACIT TS-G) satisfaction item will be administered to measure participants' satisfaction with the exercise session. This is a 1-item measure with scores range from 0 (poor) to 4 (excellent) with a higher score indicating a better outcome, with a goal of a at least a mean rating of "2." Day 1 (after the 10 minute walking session)
Primary Total Number of Participants Recruited A priori success benchmark of recruitment efficiency will be the ability to recruit 12 participants for the study. Up to 12 weeks
Primary Percentage of Ecological Momentary Assessment Data Collected A priori success benchmark for collecting ecological momentary assessment data would be to collect =80% of mood (Feeling Scale and HR) data as proposed using 2-minute intervals over two, 10-minute exercise sessions. Up to 12 weeks
Secondary Score on Positive Items from the Positive and Negative Affect Scale-SF (PANAS-SF) The Positive and Negative Affect Scale-SF (PANAS-SF) is a scale that consists of different words that describe feelings and emotions. 10 positive items will be used to assess affect. Scores range from 1-5 with a higher score indicating a a more positive affect. The final score is the sum of the scores for the positive items which ranges from 10 (minimum) to 50 (maximum) with a higher score indicating a more positive affect. 10 minutes (after start of walking session)
Secondary Score on Positive Items from the Physical Activity Affect Scale (PAAS) The PAAS is a self-report measure administered during exercise for measuring affect, only the 3 positive items will be administered. Scores range from 0-4 with a "4" indicating a better outcome. The mean of the three positive items on the scale will be taken to calculate the final score which ranges from 0 (minimum) to 4 (maximum), with a higher score indicating a better outcome. 10 minutes (after start of walking session)
Secondary Borg Dyspnea and Fatigue Scale Score The Borg Dyspnea and Fatigue Scale are 1-item scales used to measure shortness of breath and fatigue. The score range from 0 (nothing at all) to 10 (very, very severe) with a lower score indicating feeling less of this symptom. 10 minutes (after start of walking session)
Secondary Feeling Scale Score The Feeling Scale is 1-item that measures mood ranging from -5 indicating "very bad" to +5 indicating "very good" when asked how they are feeling. Up to 10 minutes (after start of walking session)
Secondary Heart Rate Pulsoximeter will be used to measure heart rate. Up to 10 minutes (after start of walking session)
Secondary Dyspnea Anxiety Scale Dyspnea Anxiety Scale is a 1-item, 0-100 Visual Analog Scale with scores ranging from 0-100. 0 meaning "not at all anxious" and 100 meaning "extremely anxious." 10 minutes (after start of walking session)
See also
  Status Clinical Trial Phase
Completed NCT04037436 - Functional Exercise and Nutrition Education Program for Older Adults N/A
Completed NCT00783978 - Surfactant Disorders and Chronic Lung Disease N/A
Not yet recruiting NCT05025774 - Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
Completed NCT04663685 - MoveStrong at Home: A Feasibility Study of a Model for Remote Delivery of Functional Strength and Balance Training Combined With Nutrition Education for Older Pre-frail Adults. N/A
Recruiting NCT06112730 - Nutritional Supplementation in Patients With Chronic Respiratory Disease N/A
Not yet recruiting NCT03180164 - Depression in Chronic Airways Diseases N/A
Completed NCT02544984 - The Anti-inflammatory Effect of Prophylactic Macrolides on Children With Chronic Lung Disease N/A
Recruiting NCT01721655 - Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease Phase 2/Phase 3
Completed NCT00233064 - Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis) Phase 4
Recruiting NCT05866302 - Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
Not yet recruiting NCT06326957 - Reducing Chronic Breathlessness in Adults by Following a Self-guided, Internet Based Supportive Intervention (SELF-BREATHE) N/A
Completed NCT01326611 - Efficacy of Clarithromycin Treatment in Prevention of Chronic Lung Disease in Premature Infants Phase 4
Completed NCT03773991 - Dyspnea Assessment in Hemodialysis Patients
Completed NCT02055339 - Pilot Study Comparing Different Modes of Non-invasive Ventilation for the Oral Feeding of Preterm Infants N/A
Withdrawn NCT03673566 - Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - CHMCO N/A
Completed NCT02426112 - Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children Phase 3
Recruiting NCT00710112 - Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
Withdrawn NCT03673579 - Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - MHSB N/A
Active, not recruiting NCT03018717 - Integral Clinical Plan Shared With or Without Telemonitoring of Constants in Patient With Chronic Diseases N/A
Completed NCT03385330 - BPD Saturation TARgeting N/A